A novel histone deacetylase inhibitor exerts promising anti‐breast cancer activity via triggering AIFM1‐dependent programmed necrosis

Detalles Bibliográficos
Autores principales: Shan, Peipei, Yang, Feifei, Yu, Jie, Wang, Lirong, Qu, Yuhua, Qiu, Huiran, Zhang, Hua, Zhu, Sujie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648389/
https://www.ncbi.nlm.nih.gov/pubmed/36161715
http://dx.doi.org/10.1002/cac2.12362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648389/
https://www.ncbi.nlm.nih.gov/pubmed/36161715
http://dx.doi.org/10.1002/cac2.12362

Ejemplares similares